Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults
収録刊行物
-
- J Acquir Immune Defic Syndr
-
J Acquir Immune Defic Syndr 31 (5), 478-482, 2002